Clinical Trial Update: Safety and Comfort of AL-4943A Ophthalmic Solution [Phase 1]

View source ↗

Summary

Phase 1 trial update assessing safety and comfort of AL-4943A ophthalmic solution for allergic conjunctivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• AL-4943A Ophthalmic Solution (AL-4943A)

Snippet

Sponsor: Alcon Research | Conditions: Allergic Conjunctivitis | Phase 1 | Status: COMPLETED